Angiotech Pharmaceuticals hires senior marketing vice-president
Vancouver-based Angiotech Pharmaceuticals has appointed Chris Dennis to the position of senior vice-president of sales and marketing. Dennis was most recently global president of OrthoNeutrogena, a Johnson & Johnson company specializing in pharmaceuticals and aesthetic devices. He has also worked as vice-president of marketing and sales at Janssen Ortho and as president of LifeScan Canada, as well as at McNeil Consumer Products and Bristol Myers Products Canada. Angiotech develops treatments for diseases or complications associated with medical device implants, surgical interventions and acute injury.